Owner Scorecard


← Japan catalog ← 4568 Manual 4661 → ← 4568 Pharmaceuticals AAPG →

4578 · Otsuka Holdings

Pharma Asset-light compounder IFRS
Latest filing: FY2025 annual securities report (有価証券報告書) · EDINET
4578 · Otsuka Holdings

This is a quantitative scorecard. The numbers below are read directly from Otsuka Holdings’s EDINET filing, in yen. The Japanese-language narrative, what the business does, its risks, what changed this year, is not machine-read here, so we do not paraphrase it. Find it on EDINET (code 4578) →

Where the money comes from

on EDINET →

The biggest segment, Pharmaceuticals, is also where the profit is made: 71% of revenue and 83% of segment operating profit.

Revenue by reportable segment, FY2025
Operating profit same segments
  • Pharmaceuticals71%¥1.74T83% of profit
  • Nutraceuticals23%¥577.7B11% of profit
  • Other5%¥115.9B1% of profit
  • Consumer Products1%¥34.6B5% of profit

From the segment footnote of the company's own annual securities report. Shares are of total revenue; the profit bar shows each segment's share of segment operating profit, before unallocated corporate costs.

I

The record

What the business has done across the cycle, read straight from the EDINET filing: the multi-year record, and the walk from reported profit to the cash an owner could take out.

The record, 2016–2025

realized figures from each filing · older years to the left
2016’162017’172018’182019’192020’202021’212022’222023’232024’242025’25
Income statement
¥1.20T¥1.24T¥1.29T¥1.40T¥1.42T¥1.50T¥1.74T¥2.02T¥2.33T¥2.47TRevenueRevenue
¥944.9B¥983.1B¥1.67T¥1.77TGross profitGross prof.
68%69%72%72%Gross marginGross mgn
40%40%41%41%SG&A / revenueSG&A/rev
0%0%0%0%R&D / revenueR&D/rev
¥83.4B¥35.1B¥108.3B¥176.6B¥198.6B¥154.5B¥150.3B¥139.6B¥323.6B¥479.4BOperating incomeOp. inc.
7.0%2.8%8.4%12.6%14.0%10.3%8.6%6.9%13.9%19.4%Operating marginOp. mgn
¥92.6B¥112.5B¥82.5B¥127.2B¥148.1B¥125.5B¥133.9B¥121.6B¥343.1B¥363.1BNet incomeNet inc.
Cash flow & returns
¥142.0B¥102.8B¥135.8B¥192.6B¥232.8B¥228.9B¥211.8B¥283.2B¥354.6B¥403.6BOperating cash flowOp. cash
¥59.3B¥75.7B¥79.4B¥84.9B¥93.8B¥97.8B¥108.0B¥116.2BDepreciationDeprec.
¥49.4B(¥9.7B)(¥5.9B)(¥10.2B)¥5.3B¥18.5B(¥15.8B)¥63.8B(¥96.5B)(¥75.7B)Working capital & otherWC & other
¥57.1B¥48.6B¥48.8B¥52.5B¥60.9B¥90.7B¥95.6B¥87.8BCapexCapex
4.4%3.5%3.4%3.5%3.5%4.5%4.1%3.6%Capex / revenueCapex/rev
¥78.7B¥144.0B¥184.0B¥176.4B¥150.9B¥192.5B¥259.1B¥315.7BOwner earningsOwner earn.
6.1%10.3%12.9%11.8%8.7%9.5%11.1%12.8%Owner earnings marginOE mgn
¥78.7B¥144.0B¥184.0B¥176.4B¥150.9B¥192.5B¥259.1B¥315.7BFree cash flowFCF
6.1%10.3%12.9%11.8%8.7%9.5%11.1%12.8%Free cash flow marginFCF mgn
¥54.2B¥54.2B¥55.3B¥55.6B¥55.7B¥56.0B¥55.6B¥55.7B¥66.8B¥71.0BDividends paidDiv. paid
¥2M¥2M¥1M¥1M¥1M¥1M¥0¥1M¥50.0B¥70.1BBuybacksBuybacks
4%2%5%8%9%7%6%5%10%14%ROICROIC
5%6%5%7%8%6%6%5%13%12%Return on equityROE
2%3%2%4%5%3%4%3%10%10%Retained to equityRetained/eq
Balance sheet
¥112.8B¥50.0B¥285.0B¥334.0B¥356.9B¥410.7B¥471.6B¥513.3B¥426.2B¥534.6BCash & investmentsCash+inv
¥250.1B¥219.8B¥933.1B¥988.4B¥1.00T¥1.05T¥1.19T¥1.33T¥1.37T¥1.62TCurrent assetsCur. assets
¥32.3B¥19.3B¥76.2B¥98.9B¥110.7B¥98.8B¥127.4B¥72.0B¥228.2B¥217.0BCurrent liabilitiesCur. liab.
7.7×11.4×12.2×10.0×9.1×10.6×9.4×18.4×6.0×7.5×Current ratioCurr. ratio
¥281.0B¥274.8B¥262.9B¥295.7B¥335.4B¥379.0B¥449.5B¥510.0BGoodwillGoodwill
¥2.48T¥2.48T¥2.48T¥2.58T¥2.63T¥2.82T¥3.10T¥3.36T¥3.74T¥4.20TTotal assetsAssets
¥125M¥108M¥205.9B¥253.3B¥226.1B¥212.5B¥194.2B¥214.2B¥189.4B¥228.0BTotal debtDebt
(¥112.6B)(¥49.9B)(¥79.1B)(¥80.7B)(¥130.8B)(¥198.2B)(¥277.5B)(¥299.2B)(¥236.8B)(¥306.7B)Net debt / (cash)Net debt
83376.0×13.6×23.5×16.2×31.9×24.8×21.4×36.8×17.7×Interest coverageInt. cov.
¥1.71T¥1.79T¥1.70T¥1.77T¥1.85T¥2.01T¥2.23T¥2.39T¥2.73T¥3.03TShareholders’ equityEquity
Per share
558M558M558M558M558M558M558M558M552M543MShares out (diluted)Shares
¥2143.19¥2222.79¥2316.06¥2502.96¥2550.62¥2685.87¥3115.61¥3618.57¥4220.57¥4546.86Revenue / shareRev/sh
¥165.93¥201.66¥147.88¥227.94¥265.56¥224.91¥240.05¥218.01¥621.57¥668.80EPS (diluted)EPS
¥141.16¥258.20¥329.91¥316.24¥270.51¥345.08¥469.33¥581.48Owner earnings / shareOE/sh
¥141.16¥258.20¥329.91¥316.24¥270.51¥345.08¥469.33¥581.48Free cash flow / shareFCF/sh
¥97.13¥97.13¥99.12¥99.60¥99.84¥100.36¥99.60¥99.77¥120.94¥130.71Dividends / shareDiv/sh
¥102.32¥87.13¥87.48¥94.03¥109.26¥162.66¥173.10¥161.77Cap. spending / shareCapex/sh
¥3066.37¥3214.71¥3055.56¥3166.29¥3320.65¥3604.99¥3989.09¥4291.02¥4951.92¥5586.57Book value / shareBVPS
Per-share growththe realized rate an owner's share compounded
9-yr5-yr
Revenue / share+8.7%/yr+12.3%/yr
Owner earnings / share+22.4%/yr (7-yr)+12.0%/yr
EPS+16.8%/yr+20.3%/yr
Dividends / share+3.4%/yr+5.5%/yr
Capital spending / share+6.8%/yr (7-yr)+13.1%/yr
Book value / share+6.9%/yr+11.0%/yr

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business reported ¥363.1B of profit but ¥315.7B of owner earnings: ¥47.4B less than the profit line, taken out by capital spending and the timing of cash.

Reported net income¥363.1B
Owner earnings¥315.7B · 13% of revenue
FY2025FY2024FY2023FY2022FY2021
Reported net income¥363.1B¥343.1B¥121.6B¥133.9B¥125.5B
Depreciation & amortizationnon-cash charge added back+¥116.2B+¥108.0B+¥97.8B+¥93.8B+¥84.9B
Working capital & othertiming of cash in and out, other non-cash items−¥75.7B−¥96.5B+¥63.8B−¥15.8B+¥18.5B
Cash from operations¥403.6B¥354.6B¥283.2B¥211.8B¥228.9B
Capital expenditurecash put back in to keep running and to grow−¥87.8B−¥95.6B−¥90.7B−¥60.9B−¥52.5B
Owner earnings¥315.7B¥259.1B¥192.5B¥150.9B¥176.4B
Owner-earnings marginowner earnings ÷ revenue13%11%10%9%12%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position .

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

II

Quality & stewardship

Returns, the balance sheet, and stewardship. The same checks the US pages run, in yen.

Peers, Pharmaceuticals

The same industry, side by side on owner economics. Each column names the period it is read over, and a median resting on fewer than three years carries that count beside it; the group median at the foot is the line to read each figure against.

CompanyRevenuelatest FY, USDGross marginmedian over the recordOp. marginmedian over the recordROICmedian over the recordOwner earn. marginmedian over the record
TEVATeva Pharmaceutical Industries Limited$17.3B48%-2.2%-2%6%
4578Otsuka Holdings$15.6B70%4y9.5%6%11%
REGNRegeneron Pharmaceuticals Inc.$14.3B96%2y34.6%21%31%
VTRSViatris$14.3B35%2.5%0%14%
NVSNovartis AG$14.0B126.2%1y126%1y
4503Astellas Pharma$13.5B81%4y11.4%9%18%
4568Daiichi Sankyo$13.4B67%4y9.2%8%7%
VRTXVertex Pharmaceuticals Incorporated$12.0B87%31.8%36%34%
Group median70%10.5%8%16%

Owner’s Scorecard

FY2025 Annual securities report · source on EDINET →

Will it survive?

  • Comfortable
    Operating income ¥479.4B ÷ interest expense ¥27.0B
    What this means

    Operating profit covers interest with the kind of margin Graham wanted for a defensive holding. Necessary, not sufficient, it says solvent, not cheap.

  • Net cash
    Cash ¥534.6B − debt ¥228.0B
    What this means

    Cash and short-term investments exceed every dollar of debt by ¥306.7B, on net the company owes nothing, and can act from strength when others can't. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

Is it a good business?

  • Below average through the cycle
    10-yr median, range 2%–14%; 14% latest = NOPAT ¥378.7B ÷ invested capital ¥2.73T
    Industry peers: median 17%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 10 years (it ran 14% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • Solid through the cycle
    8-yr median margin, range 6%–13%; latest ¥315.7B = operating cash ¥403.6B − maintenance capex ¥87.8B
    Industry peers: median 14%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 13% of revenue this year, a 11% median across 8 years.

  • Cash-backed
    Cash from ops ¥403.6B ÷ net income ¥363.1B
    What this means

    How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.

How is the cash used?

  • Returns about half
    Dividends + buybacks ¥141.1B ÷ Owner Earnings ¥315.7B — this fiscal year
    What this means

    Of ¥315.7B Owner Earnings, ¥141.1B (45%) went back to shareholders, ¥71.0B dividends, ¥70.1B buybacks. Returning most of it is the mark of a mature business with little left to reinvest at a high return; reinvesting most could mean a long runway, or empire-building. The split doesn't say which; the return earned on it (see ROIC) does. This year's proportion is 45%; across the record (2018–2025) it is 39%, the capital-allocation section below.

  • Investing or harvesting? 0.76×
    Harvesting
    Capex ¥87.8B ÷ depreciation ¥116.2B
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

Durability & moat, 2016–2025

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 10 of 10
    What this means

    Never lost money over the record, the earnings stability Graham insisted on.

  • Return on capital ≥ 15% 0 of 10 yrs
    What this means

    A moat shows up as a high return on invested capital that holds year after year, not one good vintage.

  • Operating margin 6% → 13% (3-yr avg ends)
    What this means

    Through the cycle the operating margin widened — about 6% early to 13% lately, median 9% — pricing power intact or improving.

  • Reinvestment, incremental ROIC 24%
    What this means

    Every extra dollar the business reinvested came back at a high incremental return — the lens GBM read for a moat that reinvests rather than merely harvests. The record and the 10-K are where you check whether the rate holds.

  • Owner earnings growth +15%/yr
    What this means

    Owner earnings grew about 15% a year over the record.

  • Worst year 2017 · 2.8% op. margin
    What this means

    Stayed profitable even in its hardest year, the resilience that survives recessions.

  • Share count −0.3%/yr
    What this means

    Roughly flat share count, little dilution, little buyback.

  • Dividend record rising
    What this means

    Paid and raised the dividend across the record, the continuity Graham prized.

All figures as filed; the source filing is linked above.

How the cash was used, 2018–2025

Over the record, the business generated ¥2.04T of operating cash; how management split it reads as a balanced allocator, splitting cash between the business, owners, and the balance sheet.

  • Reinvested¥542.0B · 27%
  • Dividends¥471.5B · 23%
  • Buybacks¥120.1B · 6%
  • Retained (debt / cash)¥909.8B · 45%
  • Returned to owners¥591.6B

    39% of the owner earnings the business produced over the span, ¥471.5B as dividends and ¥120.1B as buybacks.

  • Average price paid for buybacks

    Buybacks ran ¥120.1B over the span, but the filings don't tag the share count needed to deduce the average price paid.

  • Net change in share count−2.7%

    The diluted count fell from 558M to 543M, so the buybacks outran the stock issued to staff.

  • Dividend record¥130.71/sh

    Paid in 8 of the years on record, the per-share dividend growing about 4% a year. It was never cut over the span.

  • Return on what it retained14%

    Of the earnings it kept rather than paid out (¥853.4B over the span), annual owner earnings (first three years vs last three) grew ¥120.2B, so each retained ¥1 added about 0.14 of yearly owner earnings. Buffett's test, run on owner earnings instead of market value.

Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.

III

The price

What a price would have to assume, set against the record above.

What the price implies

reverse-DCF

Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Otsuka Holdings has delivered.

Otsuka Holdings’s latest year runs above its own through-cycle margin — the reported figure may flatter a peak. So the tool opens on the through-cycle base, Graham’s averaging cutting both ways; clear the toggle below to read the latest year exactly as reported.

¥

Through the cycle, Otsuka Holdings earns about ¥264.6B on its 10.7% median owner-earnings margin. This year’s 12.8% margin runs above that; the reported figure may flatter a peak you'd be paying on. Normalize, below, values the price on that through-cycle figure rather than the latest year. It comes pre-checked here for that reason, the same rule that already normalizes a trough; clear it to price the year as filed.

Base

The assumptions

9.0% = the 4.71% 10-year Treasury (Aug 18, 2026) + 4.29 points of equity premium. The rate you require is yours to set.

Enter a price above to run it.

Implied by the price
Owner-earnings growth · ’21→’25+15%/yr
Owner-earnings growth · ’18→’25+15%/yr
Owner-earnings yield
P/E (3-yr earnings ’23–’25)
P/B
Graham’s price gate

Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.

Against a high-grade bond: Graham’s yardstick bond yield%

Prefilled with the 10-year Treasury (4.71%, as of Aug 18, 2026). Edit it for today’s exact figure, or a AAA corporate yield.

Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.

Owner earnings ¥315.7B on 543M diluted shares; net cash ¥306.7B. The base opens on the through-cycle figure (the latest year sits above the record’s own median, and Graham’s averaging cuts both ways); clear Normalize to use the year as filed. Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.

Figures from EDINET, the Financial Services Agency’s disclosure system, the same kind of filing the US pages draw from EDGAR. A separate pool: these names never pass through the US industry classifier.

Manual order: ← 4568 its page in the Manual 4661 →

Industry order: ← 4568 the Pharmaceuticals chapter AAPG →